Campus Venlo, Maastricht University, Venlo, The Netherlands.
Department of Clinical Chemistry, VieCuri Medical Center Noord-Limburg, Venlo, The Netherlands.
Scand J Med Sci Sports. 2020 Oct;30(10):1888-1895. doi: 10.1111/sms.13755. Epub 2020 Aug 13.
To study the effects of running with/without the use of pain killers on urinary neutrophil gelatinase-associated lipocalin (uNGAL) and other parameters of kidney function in recreational runners.
Participants of the 10- and 21.1-km Weir Venloop race were enrolled and their urine samples collected before and after the run. Urine dipstick and other conventional tests used to assess kidney function were performed. The presence of ibuprofen, diclofenac, naproxen, and/or paracetamol was assessed by LC-MS/MS. uNGAL was measured with a two-step chemiluminescent immunoassay.
NSAIDs/analgesics were detected in urine of 5 (14.4%) 10-km runners and 13 (28.9%) 21.1-km runners. Only half-marathon participants showed significant increases in uNGAL (pre: 11.7 [7.1-34.3] ng/mL; post: 33.4 [17.4-50.4] ng/mL; P = .0038). There was a significant effect of NSAID/analgesic use on uNGAL increase (F = 4.210, P = .004). Post hoc tests revealed that uNGAL increased significantly in runners who tested positive for ibuprofen/naproxen compared to runners who did not use any medications (P = .045) or those who tested positive for paracetamol (P = .033). Running distance had a significant influence on the increase in uNGAL (F = 4.741, P < .05), specific gravity (F = 9.231, P < .01), urinary creatinine (F = 10.574, P < .01), albumin (F = 4.888, P < .05), and development of hematuria (χ (4) = 18.44, P = .001).
Running distance and use of ibuprofen/naproxen were identified as risk factors for uNGAL increase in recreational runners.
研究在休闲跑者中,使用或不使用止痛药跑步对尿中性粒细胞明胶酶相关脂质运载蛋白(uNGAL)和其他肾功能参数的影响。
招募参加 10 公里和 21.1 公里 Weir Venloop 比赛的选手,并在跑步前后采集他们的尿液样本。使用尿液试纸和其他常规测试来评估肾功能。使用 LC-MS/MS 评估布洛芬、双氯芬酸、萘普生和/或扑热息痛的存在。使用两步化学发光免疫测定法测量 uNGAL。
在 5 名(14.4%)10 公里跑者和 13 名(28.9%)21.1 公里跑者的尿液中检测到 NSAIDs/镇痛药。只有半程马拉松选手的 uNGAL 显著增加(跑步前:11.7 [7.1-34.3]ng/mL;跑步后:33.4 [17.4-50.4]ng/mL;P=0.0038)。NSAID/镇痛药的使用对 uNGAL 增加有显著影响(F=4.210,P=0.004)。事后检验显示,与未使用任何药物的跑步者(P=0.045)或检测出扑热息痛阳性的跑步者(P=0.033)相比,检测出布洛芬/萘普生阳性的跑步者的 uNGAL 显著增加。跑步距离对 uNGAL 的增加有显著影响(F=4.741,P<.05),尿比重(F=9.231,P<.01),尿肌酐(F=10.574,P<.01),白蛋白(F=4.888,P<.05)和血尿的发生(χ(4)=18.44,P=0.001)。
跑步距离和布洛芬/萘普生的使用被确定为休闲跑者 uNGAL 增加的危险因素。